Radioimmunoassay for 21-deoxycortisol: clinical applications. 1985

B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien

A radioimmunoassay for 21-deoxycortisol is described. The immunogen, 21-deoxycortisol-3-(0-carboxymethyl) oxime-bovine serum albumin, was prepared, the antisera raised against it were studied and the reliability of the assay was checked. The antiserum selected cross-reacted with 11-deoxycortisol (0.08%), corticosterone (0.25%), cortisol (0.6%) and 17-hydroxyprogesterone (1.6%). 21-deoxycortisol was separated by celite partition chromatography and eluted in the 70/30 (v/v) isooctane/ethyl acetate fraction together with 11-deoxycortisol and corticosterone. The radioimmunoassay was used to measure 21-deoxycortisol in the plasma of normal subjects and patients with androgen excess. In normal subjects, men (0.19 ng/ml +/- 0.08) and women (0.18 ng/ml +/- 0.09) had similar basal levels (mean +/- SD). One hour after ACTH stimulation, these levels were increased by a factor of 3.5. In 7 patients treated for classical congenital adrenal hyperplasia associated with 21-hydroxylase deficiency, basal values varied between 9.1 and 39.9 ng/ml (measured at 8 a.m.). In 7 untreated women with late-onset congenital adrenal hyperplasia (with 21-hydroxylase deficiency), ACTH-stimulated levels were increased to between 9 and 25.5 ng/ml. In 14 heterozygous carriers of 21-hydroxylase deficiency, diagnosed by HLA genotyping, all ACTH-stimulated levels were well above the highest corresponding levels in normal subjects, whereas 17-hydroxyprogesterone levels remained within the normal range in 9 of the cases.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003350 Cortodoxone 17,21-Dihydroxypregn-4-ene-3,20-dione. A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities. 11-Deoxycortisol,11-Desoxycortisone,Cortexolone,11-Desoxycortisol,Reichstein's Substance S,11 Deoxycortisol,11 Desoxycortisol,11 Desoxycortisone,Reichstein Substance S,Reichsteins Substance S,Substance S, Reichstein's
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005260 Female Females
D006241 Haptens Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response. Hapten,Contact-Sensitizing Agents,Agents, Contact-Sensitizing,Contact Sensitizing Agents
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006908 Hydroxyprogesterones Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.

Related Publications

B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
December 1989, Journal of steroid biochemistry,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
February 1982, Steroids,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
November 1972, Steroids,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
January 1988, Radioisotopes,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
April 1981, Clinical biochemistry,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
February 1974, Nihon Naibunpi Gakkai zasshi,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
August 1984, Journal of steroid biochemistry,
B Gueux, and J Fiet, and M T Pham-Huu-Trung, and J M Villette, and M Gourmelen, and H Galons, and J L Brerault, and P Vexiau, and R Julien
January 1994, Annals of clinical biochemistry,
Copied contents to your clipboard!